{"id":"https://openalex.org/W4253133536","doi":"https://doi.org/10.3987/com-98-8280","title":"Synthesis and Antiviral Evaluation of 3-Hydroxymethylpyrimido[1,6-c][1,3]oxazepine Derivatives","display_name":"Synthesis and Antiviral Evaluation of 3-Hydroxymethylpyrimido[1,6-c][1,3]oxazepine Derivatives","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W4253133536","doi":"https://doi.org/10.3987/com-98-8280"},"language":"en","primary_location":{"id":"doi:10.3987/com-98-8280","doi":"https://doi.org/10.3987/com-98-8280","is_oa":false,"landing_page_url":"https://doi.org/10.3987/com-98-8280","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109999787","display_name":"Ling\u2010Yih Hsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I68171755","display_name":"National Defense Medical Center","ror":"https://ror.org/02bn97g32","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I68171755"]}],"countries":["TW","US"],"is_corresponding":false,"raw_author_name":"Ling-Yih Hsu","raw_affiliation_strings":["School of Pharmacy, National Defense Medical Center, Taipei, Taiwan 100 Republic of China, Department of Biologic and Materials Sciences, School of Dentistry,","University of ~ichigan, Ann Arbor, Michigan 48109-1078, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, National Defense Medical Center, Taipei, Taiwan 100 Republic of China, Department of Biologic and Materials Sciences, School of Dentistry,","institution_ids":["https://openalex.org/I68171755"]},{"raw_affiliation_string":"University of ~ichigan, Ann Arbor, Michigan 48109-1078, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073891614","display_name":"Ya-Fun Kang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I68171755","display_name":"National Defense Medical Center","ror":"https://ror.org/02bn97g32","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I68171755"]}],"countries":["TW","US"],"is_corresponding":false,"raw_author_name":"Ya-Fun Kang","raw_affiliation_strings":["School of Pharmacy, National Defense Medical Center, Taipei, Taiwan 100 Republic of China, Department of Biologic and Materials Sciences, School of Dentistry,","University of ~ichigan, Ann Arbor, Michigan 48109-1078, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, National Defense Medical Center, Taipei, Taiwan 100 Republic of China, Department of Biologic and Materials Sciences, School of Dentistry,","institution_ids":["https://openalex.org/I68171755"]},{"raw_affiliation_string":"University of ~ichigan, Ann Arbor, Michigan 48109-1078, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110073621","display_name":"John C. Drach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I68171755","display_name":"National Defense Medical Center","ror":"https://ror.org/02bn97g32","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I68171755"]}],"countries":["TW","US"],"is_corresponding":false,"raw_author_name":"John C. Drach","raw_affiliation_strings":["School of Pharmacy, National Defense Medical Center, Taipei, Taiwan 100 Republic of China, Department of Biologic and Materials Sciences, School of Dentistry,","University of ~ichigan, Ann Arbor, Michigan 48109-1078, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, National Defense Medical Center, Taipei, Taiwan 100 Republic of China, Department of Biologic and Materials Sciences, School of Dentistry,","institution_ids":["https://openalex.org/I68171755"]},{"raw_affiliation_string":"University of ~ichigan, Ann Arbor, Michigan 48109-1078, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5763,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.64086437,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":"10","first_page":"2163","last_page":"2163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.7851999998092651,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.7851999998092651,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.07109999656677246,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.04439999908208847,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclonucleosides","display_name":"cyclonucleosides","score":0.9269999861717224},{"id":"https://openalex.org/keywords/acyclic-nucleosides","display_name":"acyclic nucleosides","score":0.7570000290870667},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.7900000214576721},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-1","display_name":"herpes simplex virus type 1","score":0.9739999771118164},{"id":"https://openalex.org/keywords/human-cytomegalovirus","display_name":"human cytomegalovirus","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.824999988079071},{"id":"https://openalex.org/keywords/breast-cancer-cell-lines","display_name":"breast cancer cell lines","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9433768391609192},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.43183478713035583},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.39299365878105164}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3987/com-98-8280","doi":"https://doi.org/10.3987/com-98-8280","is_oa":false,"landing_page_url":"https://doi.org/10.3987/com-98-8280","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W243990967"],"related_works":["https://openalex.org/W2951154361","https://openalex.org/W2018176894","https://openalex.org/W2952809771","https://openalex.org/W2007393082","https://openalex.org/W2177788793","https://openalex.org/W2951562119","https://openalex.org/W2736531671","https://openalex.org/W2055277867","https://openalex.org/W2413501400","https://openalex.org/W2063918778"],"abstract_inverted_index":{"A":[0],"number":[1],"of":[2,11,34,42,54,56,97,100,106,122,144],"pyrimido[l,6-c][1,3]oxazepin":[3],"derivatives,":[4],"the":[5,39,89,95,98,104,170],"anti":[6],"dycosidic":[7],"constrained":[8],"acyclic":[9,128],"analogs":[10],"uridine":[12],"and":[13,30,48,63,94,112,140,160],"cytidine":[14],"have":[15,65,117],"been":[16,66],"preparedCompounds":[17],"synthesized":[18,118],"were":[19,37],"evaluated":[20],"for":[21,68,77],"activity":[22,135,148],"against":[23,136,149],"herpes":[24],"simplex":[25],"virus":[26],"type":[27],"1":[28],"(HSV-1)":[29],"human":[31],"cytomegalovirus":[32],"(HCMV).All":[33],"these":[35],"compounds":[36],"inactive.From":[38],"initial":[40],"discovery":[41],"a":[43,52,119],"cyclonucleoside,":[44,123],"2',3'-0-i~oprop~lidene-0~,5-cyclocytidine":[45],"by":[46,59],"Todd":[47],"w-wokers'":[49],"in":[50],"1951,":[51],"variety":[53],"derivatives":[55,142],"cyclonucleosides":[57,73],"bridged":[58],"oxygen,":[60],"sulfur,":[61],"nitrogen":[62],"carbon":[64],"prepared":[67],"several":[69],"reasons.These":[70],"include":[71],"that":[72],"are":[74],"useful":[75],"intermediates":[76],"nucleoside":[78],"conversion,":[79],"effective":[80],"antileukemic":[81],"agents,":[82,162],"h":[83],"d":[84],"suitable":[85],"probesc7":[86],"to":[87,156,168,175],"study":[88],"relationship":[90],"between":[91],"substrate-inhibitor":[92],"conformation":[93],"specificities":[96],"enzymes":[99],"nucleic":[101],"acid":[102],"biosynthesis.In":[103],"course":[105],"our":[107],"research":[108],"concerning":[109],"new":[110,120],"antitumor":[111,159],"antiviral":[113,161],"agents,'":[114],"\"":[115],"we":[116,163],"class":[121],"namely":[124],"anti-conformationally":[125],"restricted":[126],"pyrimidine":[127],"nucleosides.We":[129],"found":[130],"6-amino-3,3-bis(hydroxymethyl)-5-methyl-1H,3H,4H-pyrimido[l,6-c][1,3]oxzazine-8-one":[131],"(I)":[132],"had":[133],"slight":[134,147],"H":[137],"N":[138],"8":[139],"3-hydroxymetyl":[141],"(II)":[143],"I":[145,166],"showed":[146],"Breast":[150],"Cancer":[151],"cell":[152],"line.l4":[153],"In":[154],"order":[155],"explore":[157],"potent":[158],"/":[164],"HO":[165],"I1began":[167],"expand":[169],"six":[171],"member":[172,177],"oxazine":[173],"ring":[174,182],"seven":[176],"oxazepin":[178],"ring.We":[179],"thought":[180],"this":[181]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-05-12T00:00:00"}